GW&K Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
970,810
+50,790
| +6% | +$1.46M | 0.25% | 160 |
|
|
2025
Q1 | $30.9M | Buy |
920,020
+240,897
| +35% | +$8.08M | 0.29% | 142 |
|
|
2024
Q4 | $34.7M | Sell |
679,123
-53,769
| -7% | -$2.75M | 0.3% | 136 |
|
|
2024
Q3 | $37.5M | Buy |
732,892
+355,229
| +94% | +$18.2M | 0.32% | 128 |
|
|
2024
Q2 | $16.9M | Sell |
377,663
-10,403
| -3% | -$466K | 0.15% | 212 |
|
|
2024
Q1 | $18.2M | Sell |
388,066
-90,997
| -19% | -$4.26M | 0.16% | 202 |
|
|
2023
Q4 | $17M | Sell |
479,063
-3,879
| -0.8% | -$138K | 0.16% | 197 |
|
|
2023
Q3 | $14.4M | Sell |
482,942
-102,798
| -18% | -$3.06M | 0.14% | 204 |
|
|
2023
Q2 | $10.6M | Buy |
585,740
+48,860
| +9% | +$880K | 0.1% | 225 |
|
|
2023
Q1 | $8.62M | Buy |
+536,880
| New | +$8.62M | 0.08% | 227 |
|